These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 12523658

  • 1. Targeting efficiency of galactosylated liposomes to hepatocytes in vivo: effect of lipid composition.
    Murao A, Nishikawa M, Managit C, Wong J, Kawakami S, Yamashita F, Hashida M.
    Pharm Res; 2002 Dec; 19(12):1808-14. PubMed ID: 12523658
    [Abstract] [Full Text] [Related]

  • 2. Effect of galactose density on asialoglycoprotein receptor-mediated uptake of galactosylated liposomes.
    Managit C, Kawakami S, Yamashita F, Hashida M.
    J Pharm Sci; 2005 Oct; 94(10):2266-75. PubMed ID: 16136555
    [Abstract] [Full Text] [Related]

  • 3. Novel galactosylated liposomes for hepatocyte-selective targeting of lipophilic drugs.
    Kawakami S, Munakata C, Fumoto S, Yamashita F, Hashida M.
    J Pharm Sci; 2001 Feb; 90(2):105-13. PubMed ID: 11169527
    [Abstract] [Full Text] [Related]

  • 4. Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting.
    Hattori Y, Kawakami S, Yamashita F, Hashida M.
    J Control Release; 2000 Dec 03; 69(3):369-77. PubMed ID: 11102677
    [Abstract] [Full Text] [Related]

  • 5. Biodistribution characteristics of mannosylated, fucosylated, and galactosylated liposomes in mice.
    Kawakami S, Wong J, Sato A, Hattori Y, Yamashita F, Hashida M.
    Biochim Biophys Acta; 2000 Dec 15; 1524(2-3):258-65. PubMed ID: 11113576
    [Abstract] [Full Text] [Related]

  • 6. Biodistribution characteristics of galactosylated emulsions and incorporated probucol for hepatocyte-selective targeting of lipophilic drugs in mice.
    Ishida E, Managit C, Kawakami S, Nishikawa M, Yamashita F, Hashida M.
    Pharm Res; 2004 Jun 15; 21(6):932-9. PubMed ID: 15212156
    [Abstract] [Full Text] [Related]

  • 7. In vivo gene delivery to the liver using novel galactosylated cationic liposomes.
    Kawakami S, Fumoto S, Nishikawa M, Yamashita F, Hashida M.
    Pharm Res; 2000 Mar 15; 17(3):306-13. PubMed ID: 10801219
    [Abstract] [Full Text] [Related]

  • 8. Targeted and sustained drug delivery using PEGylated galactosylated liposomes.
    Managit C, Kawakami S, Nishikawa M, Yamashita F, Hashida M.
    Int J Pharm; 2003 Nov 06; 266(1-2):77-84. PubMed ID: 14559396
    [Abstract] [Full Text] [Related]

  • 9. Uptake characteristics of galactosylated emulsion by HepG2 hepatoma cells.
    Managit C, Kawakami S, Yamashita F, Hashida M.
    Int J Pharm; 2005 Sep 14; 301(1-2):255-61. PubMed ID: 16076536
    [Abstract] [Full Text] [Related]

  • 10. Targeted delivery of prostaglandin E1 to hepatocytes using galactosylated liposomes.
    Kawakami S, Munakata C, Fumoto S, Yamashita F, Hashida M.
    J Drug Target; 2000 Sep 14; 8(3):137-42. PubMed ID: 10938523
    [Abstract] [Full Text] [Related]

  • 11. Asialoglycoprotein receptor-mediated gene transfer using novel galactosylated cationic liposomes.
    Kawakami S, Yamashita F, Nishikawa M, Takakura Y, Hashida M.
    Biochem Biophys Res Commun; 1998 Nov 09; 252(1):78-83. PubMed ID: 9813149
    [Abstract] [Full Text] [Related]

  • 12. Analysis of hepatic disposition of galactosylated cationic liposome/plasmid DNA complexes in perfused rat liver.
    Fumoto S, Nakadori F, Kawakami S, Nishikawa M, Yamashita F, Hashida M.
    Pharm Res; 2003 Sep 09; 20(9):1452-9. PubMed ID: 14567641
    [Abstract] [Full Text] [Related]

  • 13. Effect of gal/GalNAc regioisomerism in galactosylated liposomes on asialoglycoprotein receptor-mediated hepatocyte-selective targeting in vivo.
    Nie H, Qiu B, Yang QX, Zhao Y, Liu XM, Zhang YT, Liao FL, Zhang SY.
    J Liposome Res; 2021 Mar 09; 31(1):79-89. PubMed ID: 31691619
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Involvement of serum mannan binding proteins and mannose receptors in uptake of mannosylated liposomes by macrophages.
    Opanasopit P, Higuchi Y, Kawakami S, Yamashita F, Nishikawa M, Hashida M.
    Biochim Biophys Acta; 2001 Mar 09; 1511(1):134-45. PubMed ID: 11248212
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Current data on ATP-containing liposomes and potential prospects to enhance cellular energy status for hepatic applications.
    Korb V, Tep K, Escriou V, Richard C, Scherman D, Cynober L, Chaumeil J, Dumortier G.
    Crit Rev Ther Drug Carrier Syst; 2008 Mar 09; 25(4):305-45. PubMed ID: 18540841
    [Abstract] [Full Text] [Related]

  • 18. Asialoglycoprotein receptor-targeted liposomes loaded with a norcantharimide derivative for hepatocyte-selective targeting.
    Liu X, Han M, Xu J, Geng S, Zhang Y, Ye X, Gou J, Yin T, He H, Tang X.
    Int J Pharm; 2017 Mar 30; 520(1-2):98-110. PubMed ID: 28167263
    [Abstract] [Full Text] [Related]

  • 19. Biodistribution characteristics of mannosylated and fucosylated O/W emulsions in mice.
    Yeeprae W, Kawakami S, Higuchi Y, Yamashita F, Hashida M.
    J Drug Target; 2005 Mar 30; 13(8-9):479-87. PubMed ID: 16332573
    [Abstract] [Full Text] [Related]

  • 20. Cholesterol anchored arabinogalactan for asialoglycoprotein receptor targeting: synthesis, characterization, and proof of concept of hepatospecific delivery.
    Pathak PO, Nagarsenker MS, Barhate CR, Padhye SG, Dhawan VV, Bhattacharyya D, Viswanathan CL, Steiniger F, Fahr A.
    Carbohydr Res; 2015 May 18; 408():33-43. PubMed ID: 25841057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.